Cargando…

Comparative Effects of Domain-Specific Human Monoclonal Antibodies Against LGI1 on Neuronal Excitability

BACKGROUND AND OBJECTIVES: Autoantibodies to leucine-rich glioma inactivated protein 1 (LGI1) cause an autoimmune limbic encephalitis with frequent focal seizures and anterograde memory dysfunction. LGI1 is a neuronal secreted linker protein with 2 functional domains: the leucine-rich repeat (LRR) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sell, Josefine, Rahmati, Vahid, Kempfer, Marin, Irani, Sarosh R., Ritzau-Jost, Andreas, Hallermann, Stefan, Geis, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099296/
https://www.ncbi.nlm.nih.gov/pubmed/37028941
http://dx.doi.org/10.1212/NXI.0000000000200096
_version_ 1785025026988179456
author Sell, Josefine
Rahmati, Vahid
Kempfer, Marin
Irani, Sarosh R.
Ritzau-Jost, Andreas
Hallermann, Stefan
Geis, Christian
author_facet Sell, Josefine
Rahmati, Vahid
Kempfer, Marin
Irani, Sarosh R.
Ritzau-Jost, Andreas
Hallermann, Stefan
Geis, Christian
author_sort Sell, Josefine
collection PubMed
description BACKGROUND AND OBJECTIVES: Autoantibodies to leucine-rich glioma inactivated protein 1 (LGI1) cause an autoimmune limbic encephalitis with frequent focal seizures and anterograde memory dysfunction. LGI1 is a neuronal secreted linker protein with 2 functional domains: the leucine-rich repeat (LRR) and epitempin (EPTP) regions. LGI1 autoantibodies are known to interfere with presynaptic function and neuronal excitability; however, their epitope-specific mechanisms are incompletely understood. METHODS: We used patient-derived monoclonal autoantibodies (mAbs), which target either LRR or EPTP domains of LGI1 to investigate long-term antibody-induced alteration of neuronal function. LRR- and EPTP-specific effects were evaluated by patch-clamp recordings in cultured hippocampal neurons and compared with biophysical neuron modeling. K(v)1.1 channel clustering at the axon initial segment (AIS) was quantified by immunocytochemistry and structured illumination microscopy techniques. RESULTS: Both EPTP and LRR domain-specific mAbs decreased the latency of first somatic action potential firing. However, only the LRR-specific mAbs increased the number of action potential firing together with enhanced initial instantaneous frequency and promoted spike-frequency adaptation, which were less pronounced after the EPTP mAb. This also led to an effective reduction in the slope of ramp-like depolarization in the subthreshold response, suggesting K(v)1 channel dysfunction. A biophysical model of a hippocampal neuron corroborated experimental results and suggests that an isolated reduction of the conductance of K(v)1-mediated K(+) currents largely accounts for the antibody-induced alterations in the initial firing phase and spike-frequency adaptation. Furthermore, K(v)1.1 channel density was spatially redistributed from the distal toward the proximal site of AIS under LRR mAb treatment and, to a lesser extant, under EPTP mAb. DISCUSSION: These findings indicate an epitope-specific pathophysiology of LGI1 autoantibodies. The pronounced neuronal hyperexcitability and SFA together with dropped slope of ramp-like depolarization after LRR-targeted interference suggest disruption of LGI1-dependent clustering of K(+) channel complexes. Moreover, considering the effective triggering of action potentials at the distal AIS, the altered spatial distribution of K(v)1.1 channel density may contribute to these effects through impairing neuronal control of action potential initiation and synaptic integration.
format Online
Article
Text
id pubmed-10099296
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-100992962023-04-14 Comparative Effects of Domain-Specific Human Monoclonal Antibodies Against LGI1 on Neuronal Excitability Sell, Josefine Rahmati, Vahid Kempfer, Marin Irani, Sarosh R. Ritzau-Jost, Andreas Hallermann, Stefan Geis, Christian Neurol Neuroimmunol Neuroinflamm Research Article BACKGROUND AND OBJECTIVES: Autoantibodies to leucine-rich glioma inactivated protein 1 (LGI1) cause an autoimmune limbic encephalitis with frequent focal seizures and anterograde memory dysfunction. LGI1 is a neuronal secreted linker protein with 2 functional domains: the leucine-rich repeat (LRR) and epitempin (EPTP) regions. LGI1 autoantibodies are known to interfere with presynaptic function and neuronal excitability; however, their epitope-specific mechanisms are incompletely understood. METHODS: We used patient-derived monoclonal autoantibodies (mAbs), which target either LRR or EPTP domains of LGI1 to investigate long-term antibody-induced alteration of neuronal function. LRR- and EPTP-specific effects were evaluated by patch-clamp recordings in cultured hippocampal neurons and compared with biophysical neuron modeling. K(v)1.1 channel clustering at the axon initial segment (AIS) was quantified by immunocytochemistry and structured illumination microscopy techniques. RESULTS: Both EPTP and LRR domain-specific mAbs decreased the latency of first somatic action potential firing. However, only the LRR-specific mAbs increased the number of action potential firing together with enhanced initial instantaneous frequency and promoted spike-frequency adaptation, which were less pronounced after the EPTP mAb. This also led to an effective reduction in the slope of ramp-like depolarization in the subthreshold response, suggesting K(v)1 channel dysfunction. A biophysical model of a hippocampal neuron corroborated experimental results and suggests that an isolated reduction of the conductance of K(v)1-mediated K(+) currents largely accounts for the antibody-induced alterations in the initial firing phase and spike-frequency adaptation. Furthermore, K(v)1.1 channel density was spatially redistributed from the distal toward the proximal site of AIS under LRR mAb treatment and, to a lesser extant, under EPTP mAb. DISCUSSION: These findings indicate an epitope-specific pathophysiology of LGI1 autoantibodies. The pronounced neuronal hyperexcitability and SFA together with dropped slope of ramp-like depolarization after LRR-targeted interference suggest disruption of LGI1-dependent clustering of K(+) channel complexes. Moreover, considering the effective triggering of action potentials at the distal AIS, the altered spatial distribution of K(v)1.1 channel density may contribute to these effects through impairing neuronal control of action potential initiation and synaptic integration. Lippincott Williams & Wilkins 2023-04-07 /pmc/articles/PMC10099296/ /pubmed/37028941 http://dx.doi.org/10.1212/NXI.0000000000200096 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Sell, Josefine
Rahmati, Vahid
Kempfer, Marin
Irani, Sarosh R.
Ritzau-Jost, Andreas
Hallermann, Stefan
Geis, Christian
Comparative Effects of Domain-Specific Human Monoclonal Antibodies Against LGI1 on Neuronal Excitability
title Comparative Effects of Domain-Specific Human Monoclonal Antibodies Against LGI1 on Neuronal Excitability
title_full Comparative Effects of Domain-Specific Human Monoclonal Antibodies Against LGI1 on Neuronal Excitability
title_fullStr Comparative Effects of Domain-Specific Human Monoclonal Antibodies Against LGI1 on Neuronal Excitability
title_full_unstemmed Comparative Effects of Domain-Specific Human Monoclonal Antibodies Against LGI1 on Neuronal Excitability
title_short Comparative Effects of Domain-Specific Human Monoclonal Antibodies Against LGI1 on Neuronal Excitability
title_sort comparative effects of domain-specific human monoclonal antibodies against lgi1 on neuronal excitability
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099296/
https://www.ncbi.nlm.nih.gov/pubmed/37028941
http://dx.doi.org/10.1212/NXI.0000000000200096
work_keys_str_mv AT selljosefine comparativeeffectsofdomainspecifichumanmonoclonalantibodiesagainstlgi1onneuronalexcitability
AT rahmativahid comparativeeffectsofdomainspecifichumanmonoclonalantibodiesagainstlgi1onneuronalexcitability
AT kempfermarin comparativeeffectsofdomainspecifichumanmonoclonalantibodiesagainstlgi1onneuronalexcitability
AT iranisaroshr comparativeeffectsofdomainspecifichumanmonoclonalantibodiesagainstlgi1onneuronalexcitability
AT ritzaujostandreas comparativeeffectsofdomainspecifichumanmonoclonalantibodiesagainstlgi1onneuronalexcitability
AT hallermannstefan comparativeeffectsofdomainspecifichumanmonoclonalantibodiesagainstlgi1onneuronalexcitability
AT geischristian comparativeeffectsofdomainspecifichumanmonoclonalantibodiesagainstlgi1onneuronalexcitability